Cargando…
The Fibrinogen/Albumin Ratio Index as an Independent Prognostic Biomarker for Patients with Combined Hepatocellular Cholangiocarcinoma After Surgery
PURPOSE: The fibrinogen/albumin ratio (FAR) is increasingly considered as a potential biomarker for predicting prognosis in various malignant tumors, whereas the value of the FAR in predicting the recurrence-free survival (RFS) in patients with combined hepatocellular cholangiocarcinoma (cHCC-CCA) a...
Autores principales: | Xu, Jiake, Li, Shaochun, Feng, Ye, Zhang, Jie, Peng, Youduo, Wang, Xiaohong, Wang, Hongwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143788/ https://www.ncbi.nlm.nih.gov/pubmed/35637941 http://dx.doi.org/10.2147/CMAR.S361462 |
Ejemplares similares
-
Albumin-to-Alkaline Phosphatase Ratio is an Independent Prognostic Indicator in Combined Hepatocellular and Cholangiocarcinoma
por: Zhang, Feng, et al.
Publicado: (2020) -
Fibrinogen/albumin ratio index is an independent predictor of recurrence-free survival in patients with intrahepatic cholangiocarcinoma following surgical resection
por: Liu, Hu, et al.
Publicado: (2021) -
Fibrinogen–Albumin Ratio Index (FARI) as a Certain Prognostic Biomarker in Pretreated Patients with Immunotherapy
por: Guo, Ziwei, et al.
Publicado: (2021) -
The fibrinogen-albumin ratio as a novel prognostic factor for elderly patients with osteosarcoma
por: Fu, Yang, et al.
Publicado: (2023) -
The Prognostic Value of the Fibrinogen-Albumin-Ratio Index (FARI) in Patients with Advanced Vulvar Cancer
por: Onoprienko, Arina, et al.
Publicado: (2022)